Navigation Links
New ACO Reinsurance Program Launched by Star Line Group, U.S. Advisors and Ascendent Care
Date:11/8/2011

am."

ACOs interested in learning more about the reinsurance program should contact Terry Chesser, U.S. Advisors at (615) 263-5901 or via email at tchesser@advisorsus.com.

Star Line Group is a leading specialty underwriting manager for Specialty Benefits, Stop Loss and Managed Care insurance and reinsurance. For more information on Star Line, visit www.starlinegroup.com or contact Dan Johnson at (612) 455-8333 or djohnson@starlinegroup.com.

U.S. Advisors is an independently owned and operated reinsurance broker/consultant dedicated solely to the Managed Care Industry with clients nationally. For more information on U.S. Advisors, visit www.advisorsus.com or contact Principals Terry Chesser at (615) 263-5901 or tchesser@advisorsus.com. Or, Richard Polay at (727) 823-4577 or rpolay@advisorsus.com

Ascendent Care is a consulting firm supporting provider organizations in their efforts to integrate and improve care with change management, care process redesign, infrastructure and capital development programs. For more information on Ascendent Care, visit www.ascendentcare.com or contact Mike Barrett directly at (321) 263-5076 or mbarrett@ascendentcare.com.  

Primary Contact:
Terry Chesser
tchesser@advisorsus.com
615-263-5901


'/>"/>
SOURCE Star Line Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for Pyridorin™
2. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
3. "PATH B": A Comprehensive Support Programme in Europe for Patients Diagnosed With Chronic Hepatitis B Launched
4. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
5. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
6. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
7. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
8. Novo Nordisk and Atlanta Area Organizations Partner on Diabetes Education Programs
9. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
10. BD Biosciences Announces Winners of Research Grant Program
11. University of Houston receives NSF grant for high school teachers program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... and technology platform company serving the global pharmaceutical, ... an Investigational New Drug (IND) application for WuXi ... has been accepted for review by the China ... In September 2012, MedImmune, the global biologics research ...
(Date:3/26/2015)... 26, 2015 PRC Clinical, a Silicon-Valley ... several management and executive appointments effective immediately. , Mike ... (CFO) and member of the Board of Directors. Daniel ... and Sue Dowden will assume the position of Senior ... Chief Operations Officer (COO), has been appointed to the ...
(Date:3/26/2015)... CINCINNATI , March 26, 2015 ... NASDAQ: SHPG ) and Cincinnati Children,s Hospital ... collaboration for rare diseases. The goal of the collaboration ... treat rare diseases with high unmet medical need ... Children,s research expertise. As a nationally ranked hospital, ...
(Date:3/26/2015)... "In America," the popular news television program that airs in ... legendary film actor James Earl Jones, has announced that it ... , Botany is commonly described as the scientific study ... bit more complicated than that. Scientists and other professionals study ... the smallest bacteria known to man to the largest trees ...
Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5
... 18 Danube Pharmaceuticals, Inc., a,privately held biopharmaceutical ... innovative drugs for ophthalmology, is pleased,to announce the ... its Chief,Executive Officer., "I am honored and ... in its history as it advances its lead ...
... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced ... will present at the,Jefferies & Co. 2nd Annual Healthcare ... Wednesday, June 25, 2008., An audio webcast of ... the webcast at: http://www.alexionpharm.com . An archived version ...
... June 18 HemoCue(R) AB, a,global point-of-care diagnostic ... Incorporated (NYSE: DGX ), today announced,that its ... point-of-care,test for screening for, diagnosing and monitoring microalbuminuria ... Food and Drug Administration (FDA). With,the FDA CLIA ...
Cached Biology Technology:Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 2HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 4HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 5
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
(Date:3/16/2015)... HANOVER, Germany , March 16, 2015 /PRNewswire/ ... DERMALOG Identification Systems GmbH will present groundbreaking innovations ... Hanover, Germany . ... DERMALOG,s latest biometric innovation is well at ... the next generation e-gate made in ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3
... which has not been seen for nearly a century, has ... be in critical danger of extinction given that the only ... (Spain). A study reveals its characteristics and the reasons ... remains critically endangered. Researchers wants to restore this floral plant ...
... Mo. Plants do not have eyes or legs, yet ... from light. This ability, called phototropism, is controlled by a ... cells. In a paper published in The Plant Cell, ... the elusive role a critical protein plays in this molecular ...
... -- University of New Hampshire scientists have received National ... experiments can be applied to understand the behavior of ... investigate large-scale biological responses to climate and land-use change. ... natural resources and the environment (NREN) and assistant professor ...
Cached Biology News:The Murcian flower has been 'revived' after 100 years 2Protein plays role in helping plants see light 2UNH researchers receive NSF grant to 'scale up' stream ecology 2UNH researchers receive NSF grant to 'scale up' stream ecology 3
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, a ... are arrayed in quadruplicate for high-quality ... specific chip layout guarantee high validity ...
... UNIchip AV-400 contains 400 unique human ... glass slide. The proteins, all extracellular ... classification, are arrayed in quadruplicate for ... a specific chip layout guarantee high ...
... glycerol stocks contained in standard 96-well microtiter ... with approximately 5,000 clones per plate. After ... well, the corresponding subplate is screened with ... positive well(s). Cells from a positive well ...
... Reticulocyte Lysate Systems(a,b,c,d) offer researchers an ... a single-tube, coupled transcription/translation system. The ... process and reduce the time required ... Standard rabbit reticulocyte lysate translations (1) ...
Biology Products: